American College of Obstetricians and Gynecologists, Washington, DC, USA.
Department of Obstetrics and Gynecology, Geisinger Medical Center, Danville,PA, USA.
J Matern Fetal Neonatal Med. 2020 Sep;33(17):2970-2975. doi: 10.1080/14767058.2019.1566311. Epub 2019 Jan 22.
Preeclampsia affects over 4% of pregnancies in the United States. Management of preeclampsia is dependent on the severity of the condition and can range from expectant management to early delivery and inpatient observation. After publication of the hypertension in Pregnancy Task Force guidelines in 2013, little is known about their implementation and acceptance by practicing obstetricians and maternal-fetal medicine (MFM) specialists. To evaluate Obstetricians' knowledge and practices regarding the management of preeclampsia. A prospective survey was administered to ob-gyns at three different hospital systems in the Northeastern United States to assess practices regarding preeclampsia management and prevention. A total of 87 out of 130 providers completed and returned a questionnaire (66.9% response rate). Providers with a subspecialty in MFM made up 44.3% of the sample. 90.7% of respondents agreed that preeclampsia is a common diagnosis in their practice, while 85% agreed that aspirin is useful for reducing a patient's risk of preeclampsia. 68.8% of providers reported not administering magnesium sulfate in labor to reduce seizure risk in patients with preeclampsia without severe features. Only 5.8% of providers reported using a preeclampsia prediction algorithm, all of whom were MFMs. Providers who specialized in MFM were more likely to prescribe aspirin for preeclampsia prevention in patients with chronic hypertension (26, 74.3% vs. 17, 39.5%, = .002). MFM specialists were also more likely to counsel patients with abnormal biomarkers on the risk of preeclampsia (23, 69.7% vs. 15, 35.7%, = .005). Efforts to inform practicing ob-gyns about the best practices for preeclampsia management and prevention have been largely successful, though there are still discrepancies between current recommendations and practice. Differences between general OBGYNs and MFM specialists were also significant with regards to practice. Given the acknowledgement of how common diagnoses of preeclampsia are in respondents' practices, better education and distribution of guidelines on management of preeclampsia is needed.
子痫前期在美国影响超过 4%的妊娠。子痫前期的管理取决于病情的严重程度,可以从期待治疗到早期分娩和住院观察。2013 年高血压在妊娠工作组指南发布后,人们对其实践和接受程度知之甚少,特别是在实践中的妇产科医生和母胎医学(MFM)专家。评估妇产科医生在子痫前期管理方面的知识和实践。在美国东北部的三个不同的医院系统对妇产科医生进行了前瞻性调查,以评估子痫前期管理和预防方面的实践。共有 130 名提供者中的 87 名完成并返回了问卷(66.9%的回应率)。有 MFM 专业的提供者占样本的 44.3%。90.7%的受访者同意子痫前期是他们实践中的常见诊断,而 85%的受访者同意阿司匹林有助于降低患者子痫前期的风险。68.8%的提供者报告在没有严重特征的子痫前期患者中,不在分娩时使用硫酸镁来降低抽搐风险。只有 5.8%的提供者报告使用子痫前期预测算法,他们都是 MFM。专门从事 MFM 的提供者更有可能为慢性高血压患者开具阿司匹林预防子痫前期(26,74.3%与 17,39.5%,= 0.002)。MFM 专家也更有可能就异常生物标志物患者子痫前期的风险向患者提供咨询(23,69.7%与 15,35.7%,= 0.005)。尽管当前的建议与实践之间仍存在差异,但为实践中的妇产科医生提供有关子痫前期管理和预防的最佳实践信息的努力已取得了很大的成功。妇产科医生和 MFM 专家之间的差异也很明显,尤其是在实践方面。鉴于受访者的实践中子痫前期诊断的常见程度,需要更好地教育和分发关于子痫前期管理的指南。